Nalazite se na CroRIS probnoj okolini. Ovdje evidentirani podaci neće biti pohranjeni u Informacijskom sustavu znanosti RH. Ako je ovo greška, CroRIS produkcijskoj okolini moguće je pristupi putem poveznice www.croris.hr
izvor podataka: crosbi

Current Trends in Development of Liposomes for Targeting Bacterial Biofilms (CROSBI ID 229203)

Prilog u časopisu | pregledni rad (znanstveni) | međunarodna recenzija

Rukavina, Zora ; Vanić, Željka Current Trends in Development of Liposomes for Targeting Bacterial Biofilms // Pharmaceutics, 8 (2016), 2; 18, 26. doi: 10.3390/pharmaceutics8020018

Podaci o odgovornosti

Rukavina, Zora ; Vanić, Željka

engleski

Current Trends in Development of Liposomes for Targeting Bacterial Biofilms

Biofilm targeting represents a great challenge for effective antimicrobial therapy. Increased biofilm resistance, even with the elevated concentrations of very potent antimicrobial agents, often leads to failed therapeutic outcome. Application of biocompatible nanomicrobials, particularly liposomally-associated nanomicrobials, presents a promising approach for improved drug delivery to bacterial cells and biofilms. Versatile manipulations of liposomal physicochemical properties, such as the bilayer composition, membrane fluidity, size, surface charge and coating, enable development of liposomes with desired pharmacokinetic and pharmacodynamic profiles. This review attempts to provide an unbiased overview of investigations of liposomes destined to treat bacterial biofilms. Different strategies including the recent advancements in liposomal design aiming at eradication of existing biofilms and prevention of biofilm formation, as well as respective limitations, are discussed in more details.

liposomes ; biofilm ; antimicrobial ; infection ; drug delivery ; physicochemical properties

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

nije evidentirano

Podaci o izdanju

8 (2)

2016.

18

26

objavljeno

1999-4923

10.3390/pharmaceutics8020018

Povezanost rada

Farmacija

Poveznice
Indeksiranost